Thomas Schreiner

     

    Publications 2019

    Göldi M, van Poppel EAM, Rasch B, Schreiner T (2019)
    Increased neuronal signatures of targeted memory reactivation during slow-wave up states
    Sci Rep, 9 (1), 2715
    DOI 10.1038/s41598-019-39178-2, PubMed 30804371

    Schreiner T, Staresina BP (2019)
    Sleep: Rock and Swing versus Toss and Turn
    Curr Biol, 29 (3), R86-R88
    DOI 10.1016/j.cub.2018.12.035, PubMed 30721679

    Publications 2018

    Cordi MJ, Schreiner T, Rasch B (2018)
    No effect of vocabulary reactivation in older adults
    Neuropsychologia, 119, 253-261
    DOI 10.1016/j.neuropsychologia.2018.08.021, PubMed 30153450

    de Blok CJM, Klaver M, Wiepjes CM, Nota NM, Heijboer AC, Fisher AD, Schreiner T, T'Sjoen G, den Heijer M (2018)
    Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study
    J Clin Endocrinol Metab, 103 (2), 532-538
    DOI 10.1210/jc.2017-01927, PubMed 29165635

    Limmroth V, Bartzokis I, Bonmann E, Kusel P, Schreiner T, Schürks M (2018)
    The BETACONNECT™ system: MS therapy goes digital
    Neurodegener Dis Manag, 8 (6), 399-410
    DOI 10.2217/nmt-2018-0030, PubMed 30278827

    Pötter R, Balosso J, Baumann M, Bert C, Davies J, Enghardt W, Fossati P, Harris S, Jones B, Krämer M, Mayer R, Mock U, Pullia M, Schreiner T, Dosanjh M, Debus J, Orecchia R, Georg D, ULICE Collaborative Research Group (2018)
    Union of light ion therapy centers in Europe (ULICE EC FP7) - Objectives and achievements of joint research activities
    Radiother Oncol, 128 (1), 83-100
    DOI 10.1016/j.radonc.2018.04.027, PubMed 30001932

    Schreiner T, Doeller CF, Jensen O, Rasch B, Staudigl T (2018)
    Theta Phase-Coordinated Memory Reactivation Reoccurs in a Slow-Oscillatory Rhythm during NREM Sleep
    Cell Rep, 25 (2), 296-301
    DOI 10.1016/j.celrep.2018.09.037, PubMed 30304670

    Publications 2017

    Defreyne J, Nota N, Pereira C, Schreiner T, Fisher AD, den Heijer M, T'Sjoen G (2017)
    Transient Elevated Serum Prolactin in Trans Women Is Caused by Cyproterone Acetate Treatment
    LGBT Health, 4 (5), 328-336
    DOI 10.1089/lgbt.2016.0190, PubMed 28880825

    Groch S, Schreiner T, Rasch B, Huber R, Wilhelm I (2017)
    Prior knowledge is essential for the beneficial effect of targeted memory reactivation during sleep
    Sci Rep, 7, 39763
    DOI 10.1038/srep39763, PubMed 28051138

    Göldi M, Schreiner T (2017)
    Clicking the brain into deep sleep. Commentary on Weigenand et al. ()
    Eur J Neurosci, 45 (5), 629-630
    DOI 10.1111/ejn.13494, PubMed 27973741

    Sommerkorn FM, Schauer B, Schreiner T, Fickenscher H, Krumbholz A (2017)
    Performance of Hepatitis E Virus (HEV)-antibody tests: a comparative analysis based on samples from individuals with direct contact to domestic pigs or wild boar in Germany
    Med Microbiol Immunol, 206 (3), 277-286
    DOI 10.1007/s00430-017-0503-4, PubMed 28397024

    Wiepjes CM, Vlot MC, Klaver M, Nota NM, de Blok CJ, de Jongh RT, Lips P, Heijboer AC, Fisher AD, Schreiner T, T'Sjoen G, den Heijer M (2017)
    Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study
    J Bone Miner Res, 32 (6), 1252-1260
    DOI 10.1002/jbmr.3102, PubMed 28370342

    Publications 2016

    Lehmann M, Schreiner T, Seifritz E, Rasch B (2016)
    Emotional arousal modulates oscillatory correlates of targeted memory reactivation during NREM, but not REM sleep
    Sci Rep, 6, 39229
    DOI 10.1038/srep39229, PubMed 27982120

    Schreiner T, Rasch B (2016)
    To gain or not to gain - The complex role of sleep for memory: Comment on Dumay (2016)
    Cortex, 101, 282-287
    DOI 10.1016/j.cortex.2016.06.011, PubMed 27423210

    Schreiner T, Rasch B (2016)
    The beneficial role of memory reactivation for language learning during sleep: A review
    Brain Lang, 167, 94-105
    DOI 10.1016/j.bandl.2016.02.005, PubMed 27036946

    Publications 2015

    Seland M, Bjøro T, Furre T, Schreiner T, Bollerslev J, Fosså SD, Loge JH, Holte H, Kiserud CE (2015)
    Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region
    J Cancer Surviv, 9 (4), 630-40
    DOI 10.1007/s11764-015-0439-x, PubMed 25750158

    Seland M, Holte H, Bjøro T, Schreiner T, Bollerslev J, Loge JH, Fosså SD, Kiserud CE (2015)
    Chronic fatigue is prevalent and associated with hormonal dysfunction in long-term non-Hodgkin lymphoma survivors treated with radiotherapy to the head and neck region
    Leuk Lymphoma, 56 (12), 3306-14
    DOI 10.3109/10428194.2015.1036258, PubMed 25827172

    Publications 2014

    Wierckx K, Van Caenegem E, Schreiner T, Haraldsen I, Fisher AD, Toye K, Kaufman JM, T'Sjoen G (2014)
    Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence
    J Sex Med, 11 (8), 1999-2011
    DOI 10.1111/jsm.12571, PubMed 24828032

    Publications 2013

    Jørgensen AP, Ueland T, Sode-Carlsen R, Schreiner T, Rabben KF, Farholt S, Høybye C, Christiansen JS, Bollerslev J (2013)
    Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study
    Growth Horm IGF Res, 24 (1), 16-21
    DOI 10.1016/j.ghir.2013.11.002, PubMed 24360789

    Papathomas TG, Gaal J, Corssmit EP, Oudijk L, Korpershoek E, Heimdal K, Bayley JP, Morreau H, van Dooren M, Papaspyrou K, Schreiner T, Hansen T, Andresen PA, Restuccia DF, van Kessel I, van Leenders GJ, Kros JM, Looijenga LH, Hofland LJ, Mann W, van Nederveen FH, Mete O, Asa SL, de Krijger RR, Dinjens WN (2013)
    Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis
    Eur J Endocrinol, 170 (1), 1-12
    DOI 10.1530/EJE-13-0623, PubMed 24096523

    Publications 2011

    Carlsen SM, Svartberg J, Schreiner T, Aanderud S, Johannesen O, Skeie S, Lund-Johansen M, Fougner SL, Bollerslev J, POTA study group (2011)
    Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure
    Clin Endocrinol (Oxf), 74 (6), 736-43
    DOI 10.1111/j.1365-2265.2011.03982.x, PubMed 21521254

    Ramm-Pettersen J, Berg-Johnsen J, Hol PK, Roy S, Bollerslev J, Schreiner T, Helseth E (2011)
    Intra-operative MRI facilitates tumour resection during trans-sphenoidal surgery for pituitary adenomas
    Acta Neurochir (Wien), 153 (7), 1367-73
    DOI 10.1007/s00701-011-1004-7, PubMed 21523361

    Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C (2011)
    Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study
    Endocrine, 41 (2), 191-9
    DOI 10.1007/s12020-011-9560-4, PubMed 22081257

    Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Frystyk J, Christiansen JS, Höybye C (2011)
    Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome
    Growth Horm IGF Res, 21 (4), 185-90
    DOI 10.1016/j.ghir.2011.05.002, PubMed 21664161

    Publications 2010

    Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C (2010)
    One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study
    J Clin Endocrinol Metab, 95 (11), 4943-50
    DOI 10.1210/jc.2010-0907, PubMed 20702523

    Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C (2010)
    Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome
    Growth Horm IGF Res, 20 (3), 179-84
    DOI 10.1016/j.ghir.2009.12.004, PubMed 20199883

    Tønseth KA, Bjark T, Kratz G, Gross A, Kirschner R, Schreiner T, Diseth TH, Haraldsen I (2010)
    [Sex reassignment surgery in transsexuals]
    Tidsskr Nor Laegeforen, 130 (4), 376-9
    DOI 10.4045/tidsskr.08.0670, PubMed 20220861

    Publications 2009

    Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust P, Bollerslev J (2009)
    Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly
    J Clin Endocrinol Metab, 95 (1), 361-8
    DOI 10.1210/jc.2009-0422, PubMed 19880791

    Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust PL, Bollerslev J (2009)
    Associations between Body Composition, Circulating Interleukin-1 Receptor Antagonist, Osteocalcin, and Insulin Metabolism in Active Acromegaly
    Endocr Rev, 30 (7), 927
    DOI 10.1210/edrv.30.7.9997, PubMed 28199500

    Publications 2008

    Carlsen SM, Lund-Johansen M, Schreiner T, Aanderud S, Johannesen O, Svartberg J, Cooper JG, Hald JK, Fougner SL, Bollerslev J, Preoperative Octreotide Treatment of Acromegaly study group (2008)
    Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial
    J Clin Endocrinol Metab, 93 (8), 2984-90
    DOI 10.1210/jc.2008-0315, PubMed 18492760

    Vik-Mo EO, Øksnes M, Pedersen PH, Wentzel-Larsen T, Rødahl E, Thorsen F, Schreiner T, Aanderud S, Lund-Johansen M (2008)
    Gamma knife stereotactic radiosurgery of Nelson syndrome
    Eur J Endocrinol, 160 (2), 143-8
    DOI 10.1530/EJE-08-0687, PubMed 18996962

    Publications 2007

    Vik-Mo EO, Oksnes M, Pedersen PH, Wentzel-Larsen T, Rødahl E, Thorsen F, Schreiner T, Aanderud S, Lund-Johansen M (2007)
    Gamma knife stereotactic radiosurgery for acromegaly
    Eur J Endocrinol, 157 (3), 255-63
    DOI 10.1530/EJE-07-0189, PubMed 17766706

    Publications 2006

    Bollerslev J, Ueland T, Jørgensen AP, Fougner KJ, Wergeland R, Schreiner T, Burman P (2006)
    Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency
    Eur J Endocrinol, 154 (4), 537-43
    DOI 10.1530/eje.1.02125, PubMed 16556716

    Evang JA, Carlsen SM, Svartberg J, Aanderud S, Johannesen Ø, Schreiner T, Ramm-Pettersen J, Bakke SJ, Lund-Johansen M, Bollerslev J (2006)
    [Endogenous Cushing's syndrome]
    Tidsskr Nor Laegeforen, 126 (5), 599-602
    PubMed 16505869

    Publications 2005

    Bollerslev J, Hallén J, Fougner KJ, Jørgensen AP, Kristo C, Fagertun H, Gudmundsen O, Burman P, Schreiner T (2005)
    Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial
    Eur J Endocrinol, 153 (3), 379-87
    DOI 10.1530/eje.1.01971, PubMed 16131600

    Schreiner T, Schaefer UF, Loth H (2005)
    Immediate drug release from solid oral dosage forms
    J Pharm Sci, 94 (1), 120-33
    DOI 10.1002/jps.20226, PubMed 15761936

    Publications 2003

    Lund-Johansen M, Aanderud S, Schreiner T, Bollerslev J, Bakke SJ, Johannesen Ø, Carlsen SM, Cappelen J, Svartberg J (2003)
    [Hormonally inactive pituitary adenomas]
    Tidsskr Nor Laegeforen, 123 (16), 2253-6
    PubMed 14508546

    Publications 2002

    Bjøro T, Holmen J, Krüger Ø, Midthjell K, Hunstad K, Schreiner T, Sandnes L, Brochmann H (2002)
    [Prevalence of hypothyroidism and hyperthyroidism in Nord-Trondelag]
    Tidsskr Nor Laegeforen, 122 (10), 1022-8
    PubMed 12082694

    Schreiner T, Mohrs MR, Blau-Wasser R, von Krempelhuber A, Steinert M, Schleicher M, Noegel AA (2002)
    Loss of the F-actin binding and vesicle-associated protein comitin leads to a phagocytosis defect
    Eukaryot Cell, 1 (6), 906-14
    DOI 10.1128/ec.1.6.906-914.2002, PubMed 12477791

    Svartberg J, Carlsen SM, Cappelen J, Aanderud S, Johansen ML, Schreiner T, Kollevold T, Bakke S, Bollerslev J (2002)
    [Hyperprolactinemia and prolactinemia--investigation and treatment]
    Tidsskr Nor Laegeforen, 122 (5), 494-8
    PubMed 11961978

    Page visits: 4465